Chromadex Corp
Change company Symbol lookup
Select an option...
CDXC Chromadex Corp
MITO Stealth BioTherapeutics Corp
SHOP Shopify Inc
CHMR Chimera Energy Corp
QTRX Quanterix Corp
MSEX Middlesex Water Co
EQIX Equinix Inc
PEAK Healthpeak Properties Inc
TAL TAL Education Group
CPLP Capital Product Partners LP
Go

Health Care : Life Sciences Tools & Services | Small Cap Blend
Company profile

ChromaDex Corp. is a global bioscience company, which is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. NAD+ is a coenzyme and a regulator of cellular metabolism. It operates through three segments: Consumer products, Ingredients, and Analytical reference standards and services segment. The Consumer products segment provides finished dietary supplement products that contain the ingredients directly to consumers as well as to distributors. The Ingredients segment develops and commercializes ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Analytical reference standards and services segment supplies phytochemical reference standards and other research and development services. Its ingredients include Tru Niagen and Immulina. The Tru Niagen is a form nicotinamide riboside (NR). NR is a member of the vitamin B3 family. Immulina is a spirulina extract.

Closing Price
$1.35
Day's Change
0.03 (2.27%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.45
Day's Low
1.33
Volume
(Heavy Day)
Volume:
404,988

10-day average volume:
168,325
404,988

Company Profile

ChromaDex Corp. is a global bioscience company, which is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. NAD+ is a coenzyme and a regulator of cellular metabolism. It operates through three segments: Consumer products, Ingredients, and Analytical reference standards and services segment. The Consumer products segment provides finished dietary supplement products that contain the ingredients directly to consumers as well as to distributors. The Ingredients segment develops and commercializes ingredient technologies and supplies these ingredients as raw materials to the manufacturers of consumer products. The Analytical reference standards and services segment supplies phytochemical reference standards and other research and development services. Its ingredients include Tru Niagen and Immulina. The Tru Niagen is a form nicotinamide riboside (NR). NR is a member of the vitamin B3 family. Immulina is a spirulina extract.

Valuation Ratios

Price/Earnings (TTM)
--
Price/Sales (TTM)
1.18x
Price/Book (MRQ)
3.90x
Price/Cash Flow (TTM)
--
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

Price Performance

Historic Growth and Share Detail

Historic Growth

Annual growth, past 5 years
EPS
Revenue
Dividend No Regular Dividend is paid
 

Short Interest

September 2022
Current Month
2.2M
Previous Month
2.3M
Percent of Float
5.26%
Days to Cover
18.0671 Days

Share Information

CDXC is in a share class of common stock
Float
41.0M
Shares Outstanding
68.3M
Institutions Holding Shares
88
21.67%

Financial Statements

Balance sheet

Values displayed are in thousands.

Income statement

Values displayed are in thousands.

Cash flow

Values displayed are in thousands.

Company Officers

  • Robert N. FriedCEO
  • Brianna GerberCFO
  • Ann Cohen
  • Gary Ng
  • Kristin Patrick

Address

Insider Trading

During the most recent quarter, 60K shares were bought in insider trading.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Insider trading information report provided by Copyright © 2022. All rights reserved.

Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.

Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.